BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27340772)

  • 1. Virus infection facilitates the development of severe pneumonia in transplant patients with hematologic malignancies.
    Yue C; Kang Z; Ai K; Xu D; Wu J; Pan Y; Yan J; Liu M; Liu Q
    Oncotarget; 2016 Aug; 7(33):53930-53940. PubMed ID: 27340772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.
    Gueller S; Duenzinger U; Wolf T; Ajib S; Mousset S; Berger A; Martin H; Serve H; Bug G
    Transpl Infect Dis; 2013 Aug; 15(4):435-40. PubMed ID: 23692664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center.
    Chemaly RF; Ghosh S; Bodey GP; Rohatgi N; Safdar A; Keating MJ; Champlin RE; Aguilera EA; Tarrand JJ; Raad II
    Medicine (Baltimore); 2006 Sep; 85(5):278-287. PubMed ID: 16974212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal cytomegalovirus pneumonia in patients with haematological malignancies: an autopsy-based case-control study.
    Torres HA; Aguilera E; Safdar A; Rohatgi N; Raad II; Sepulveda C; Luna M; Kontoyiannis DP; Chemaly RF
    Clin Microbiol Infect; 2008 Dec; 14(12):1160-6. PubMed ID: 19046167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies.
    Vakil E; Sheshadri A; Faiz SA; Shah DP; Zhu Y; Li L; Kmeid J; Azzi J; Balagani A; Bashoura L; Ariza-Heredia E; Chemaly RF
    Transpl Infect Dis; 2018 Dec; 20(6):e12994. PubMed ID: 30195271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo monitoring of human cytomegalovirus-specific CD8(+) T-Cell responses using the QuantiFERON-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital.
    Fleming T; Dunne J; Crowley B
    J Med Virol; 2010 Mar; 82(3):433-40. PubMed ID: 20087937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early cytomegalovirus infections following allogeneic stem cell transplantation: a comparison between non-malignant and malignant haematological disorders.
    Islam MS; Anoop P; Rice P; Benjamin R; Datta-Nemdharry P; Gordon-Smith EC; Marsh JC
    Hematology; 2010 Feb; 15(1):4-10. PubMed ID: 20132656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory viral infections during the first 28 days after transplantation in pediatric hematopoietic stem cell transplant recipients.
    Lee JH; Jang JH; Lee SH; Kim YJ; Yoo KH; Sung KW; Lee NY; Ki CS; Koo HH
    Clin Transplant; 2012; 26(5):736-40. PubMed ID: 22385011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful prevention of respiratory syncytial virus nosocomial transmission following an enhanced seasonal infection control program.
    Lavergne V; Ghannoum M; Weiss K; Roy J; Béliveau C
    Bone Marrow Transplant; 2011 Jan; 46(1):137-42. PubMed ID: 20383207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.
    Avetisyan G; Mattsson J; Sparrelid E; Ljungman P
    Transplantation; 2009 Nov; 88(10):1222-6. PubMed ID: 19935377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality.
    Liu J; Kong J; Chang YJ; Chen H; Chen YH; Han W; Wang Y; Yan CH; Wang JZ; Wang FR; Chen Y; Zhang XH; Xu LP; Liu KY; Huang XJ
    Clin Microbiol Infect; 2015 Dec; 21(12):1121.e9-15. PubMed ID: 26093077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of human herpesvirus-6 in allogeneic hematopoietic stem cell transplant recipients in correlation with cytomegalovirus infection].
    Wang LR; Dong LJ; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1204-9. PubMed ID: 17204195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation.
    McCarthy AJ; Kingman HM; Kelly C; Taylor GS; Caul EO; Grier D; Moppett J; Foot AB; Cornish JM; Oakhill A; Steward CG; Pamphilon DH; Marks DI
    Bone Marrow Transplant; 1999 Dec; 24(12):1315-22. PubMed ID: 10627641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the shedding of three β-herpesviruses DNA in Polish patients subjected to allogeneic hematopoietic stem cell transplantation: Six-year follow up.
    Dzieciatkowski T; Tomaszewska A; Przybylski M; Rusicka P; Basak GW; Jedrzejczak WW; Wroblewska M; Halaburda K
    J Clin Virol; 2016 Mar; 76():30-5. PubMed ID: 26809130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nosocomial respiratory syncytial virus infections in three cases in a bone marrow transplantation unit].
    Kalayoglu Beşişik S; Sen F; Midilli K; Yilmaz G; Ozsüt H; Calangu S; Sargin D
    Mikrobiyol Bul; 2008 Apr; 42(2):359-64. PubMed ID: 18697436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of infectious complications in allogeneic hematopoietic stem cell transplant recipients.
    Martín-Peña A; Aguilar-Guisado M; Espigado I; Parody R; Miguel Cisneros J
    Clin Transplant; 2011; 25(3):468-74. PubMed ID: 20482561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective use of oral ribavirin for respiratory syncytial viral infections in allogeneic haematopoietic stem cell transplant recipients.
    Gorcea CM; Tholouli E; Turner A; Saif M; Davies E; Battersby E; Dignan FL
    J Hosp Infect; 2017 Feb; 95(2):214-217. PubMed ID: 28077243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
    Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study.
    Chatzis O; Darbre S; Pasquier J; Meylan P; Manuel O; Aubert JD; Beck-Popovic M; Masouridi-Levrat S; Ansari M; Kaiser L; Posfay-Barbe KM; Asner SA
    BMC Infect Dis; 2018 Mar; 18(1):111. PubMed ID: 29510663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory syncytial virus infection following hematopoietic stem cell transplantation.
    Small TN; Casson A; Malak SF; Boulad F; Kiehn TE; Stiles J; Ushay HM; Sepkowitz KA
    Bone Marrow Transplant; 2002 Feb; 29(4):321-7. PubMed ID: 11896429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.